I agree Jimmy, we haven’t crossed the goal line yet but I believe we will. We should be able to hit our end points in this next trial based on the numbers from CD12. I also think it would be prudent for NP to make a deal with Philippines, Brazil, etc... and sell LL at a discount for being the first country to approve us. But beyond Covid, there is nothing working in TNBC and to have the results we have is just remarkable! I know we have multiple indications we are shooting for and eventually HIV will be lucrative, but I agree that we may become best known in oncology because we will be the only drug making a difference. I bought more today and look forward to when the test results start coming in and this thing takes off. IMO GLTA
Market Data 
Markets 
AI
